VASCUDYNE
LIVE

Serial Number

98449022

Owner

Vascudyne, Inc.

Attorney

Jenifer deWolf Paine

First Use Date

Dec 1, 2025

Filing Date

Mar 14, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VASCUDYNE Trademark

Serial Number: 98449022 • Registration: 8440163

VASCUDYNE is a trademark filed by Vascudyne, Inc. on March 14, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Vascudyne, Inc. (2 trademarks)

296 Chester Street
St. Paul, MN 55107

Entity Type: 03

Trademark Details

Filing Date

March 14, 2024

Registration Date

September 15, 2026

First Use Anywhere

December 1, 2025

First Use in Commerce

December 1, 2025

Published for Opposition

February 3, 2026

Goods & Services

Agents for medical purposes, namely, biotechnologically engineered tissue products in the nature of cells and tissue cell sheets for the treatment of cardiac disease and conditions; biotechnologically engineered tissue products, namely, cells and tissue cell sheets for medical use; regenerative biological tissue sheets for medical purposes; surgical implants comprised of living tissue; transcatheter implants comprised of living tissue; biological material, namely, tissue sheets for the treatment of wounds; biological material, namely, cells and tissue cell sheets for the treatment of damaged skin and tissue; biological tissue grafts; vascular grafts

Scientific research and development; biomedical research and development

Surgical apparatus; surgical apparatus for medical or veterinary use; medical and surgical apparatus, namely, implantable artificial cardiac valves; medical apparatus for use in percutaneous and endovascular procedures; medical apparatus for use in cardiovascular procedures; medical apparatus for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; replacement tissue valves being implants comprising artificial and natural, non-living materials for the human heart; catheters

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 15, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 17, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 17, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 11, 2026 SUPC
USE AMENDMENT FILED
Jun 25, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 25, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 31, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 9, 2026 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2026 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 6, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 5, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 2, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 2, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jan 2, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 1, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2024 NWOS
NEW APPLICATION ENTERED
Mar 14, 2024 NWAP